Streetbeat News

Products Services

KR

Baker Farms has voluntarily recalled a single production run of Kroger 16-ounce bagged Collard Greens due to possible Listeria monocytogenes contamination. The product was distributed to various Kroger retail locations in several states. No illnesses have been reported so far. Customers who have purchased the affected product are urged to dispose of it or return it to their local store for a full refund.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:58 pm

RIVN

Rivian (NASDAQ:RIVN) has announced the opening of its newest spaces location at Ponce City Market, showcasing progress on its future Georgia manufacturing facility. The facility, to be built at the Stanton Springs North site, will have an annual capacity of 400,000 units when fully complete. Site preparations are nearly complete, with a formal groundbreaking ceremony expected in early 2024. The company has also opened an office in Covington, Georgia, and continues to grow its local presence.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:29 pm

LYB

LyondellBasell has acquired a 50% stake in Rodepa Vastgoed B.V., the holding company of De Paauw Sustainable Resources (DPSR), a Dutch plastic waste recycling company. The acquisition aligns with LyondellBasell's strategy to increase access to plastic waste feedstock and expand its production of CirculenRecover products. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 3:16 pm

LLY

Eli Lilly has announced that patients with moderate-to-severe atopic dermatitis who continued treatment with investigational lebrikizumab for up to two years experienced sustained skin clearance. The results from the ADjoin long-term extension study will be presented at the 43rd Annual Fall Clinical Dermatology Conference from October 19-22. Despite the positive news, LLY shares are trading lower by 1.47% at $582.10.

Portfolio Pulse from Shivani Kumaresan

October 20, 2023 | 3:07 pm

LIPO

Shares of Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) are surging on heavy trading volume, with over 28.6 million shares traded in the session, significantly higher than its 100-day average of less than 7 thousand shares. This comes after the company published positive results from a Phase 2a clinical study of its lead product candidate, LP-10, a potential treatment for hemorrhagic cystitis. The stock is up 54% at $2.48.

Portfolio Pulse from Erica Kollmann

October 20, 2023 | 2:51 pm

SFTBY

SYM

WMT

Symbotic Inc. (NASDAQ:SYM), a robotics warehouse automation company, has partnered with SoftBank and Walmart to create GreenBox Systems, an AI-powered logistics and warehouse joint venture. SoftBank holds an 8% stake in Symbotic and a 65% stake in GreenBox, while Walmart holds an 11% stake in Symbotic. Revenue from Walmart accounts for 90% of Symbotic's total revenue. Symbotic's sales grew by 77% in the most recent quarter, and orders for its existing warehouse-management systems have surged to $12 billion.

Portfolio Pulse from Aditi Ganguly

October 20, 2023 | 2:46 pm

NIO

Anhui Jianghuai Automobile Group Corp., a key producer of electric vehicles for NIO Inc., plans to sell certain assets, including a car factory, worth around $615 million. The assets are from two manufacturing facilities that produce NIO EVs. NIO stated that this won't affect its production. NIO's vehicle deliveries for Q3 totaled 55,432, up 75.4% YoY. NIO shares are trading higher by 0.65% at $7.74.

Portfolio Pulse from Shivani Kumaresan

October 20, 2023 | 2:42 pm

JNJ

Janssen, a pharmaceutical company owned by Johnson & Johnson (JNJ), has announced that its Week 16 topline results for the Visible Cohort A study have achieved co-primary endpoints. The study shows the established efficacy and safety profile of Tremfya across different skin tones.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:31 pm

JNJ

Janssen, a pharmaceutical company of Johnson & Johnson (JNJ), announced that additional datasets showed its drug Tremfya had rapid and significant effects in clearing scalp psoriasis and improving key health-related quality of life outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:29 pm

JNJ

Janssen, a pharmaceutical company of Johnson & Johnson (JNJ), announced that its drug Tremfya demonstrated significant skin clearance in a large-scale study dedicated to people of color living with moderate to severe plaque psoriasis. This is the first study of its kind.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:29 pm